2-[[シクロプロピルメチル[[4-(4-メトキシベンゾイル)ピペリジノ]アセチル]アミノ]メチル]-3,5,7,8-テトラヒドロ-4H-ピラノ[4,3-d]ピリミジン-4-オンN-(シクロプロピルメチル)-2-[4-(4-メトキシベンゾイル)ピペリジン-1-イル]-N-({4-オキソ-3H,4H,5H,7H,8H-ピラノ[4,3-d]ピリミジン-2-イル}メチル)アセトアミドCS-1333TNKS656(NVP-TNKS656)NVP-TNKS656 - TNKS 656NVP-TNKS656, 10 mM in DMSOTNKS 656
説明NVP-TNKS656 is an orally bioavailable inhibitor of tankyrase 2 (TNKS2; IC50 = 6 nM). It is selective for TNKS2 over poly(ADP-ribose) polymerase (PARP) 1 and 2 (IC50s = >19 and 32 nM, respectively). NVP-TNKS656 inhibits Wnt ligand-induced signaling with an IC50 value of 3.5 nM in an HEK293 cell reporter assay. In vivo, NVP-TNKS656 (350 mg/kg) reduces Axin 2 mRNA expression, a Wnt/β-catenin target gene, in MMTV-Wnt1 tumor bearing mice.